Hospitals
New Insights into Prostate Cancer Therapy: Histone Deacetylase Inhibitors Show Promising Results
Research conducted at the University of Nebraska Medical Center has shed light on the potential of histone deacetylase inhibitors as a treatment for prostate cancer. The study focused on the histone deacetylase inhibitor valproic acid and its effects on prostate cancer cells. The findings suggest that valproic acid can suppress